Rui Manuel Silva

This patent-protected technology uses the manipulation of DC surface sialic acids to impact critical DC functions and is an innovative method to tackling the lack of efficacy of current immunotherapies, to improve and diversify DC-based therapies.[…]

Use of a single optical image (daylight or IR) to retrieve target metrics using aerial systems like drones. The technology works with a single image acquired by a monocular optical camera, whose acquisition parameters must be known. The camera may work in either visible or infrared spectrum. Besides[…]

The present disclosure relates to compounds and compositions for the treatment of malarian diseases. The compounds comprise a class of halogenated alkyl-aromatic secondary metabolites, including hierridic C, or pharmaceutically acceptable salts, esters, solvates or prodrugs thereof. The compounds co[…]

Resorcinol-based products for preventing and/or treating neuroinflammation and treating neurodegenerative diseases. The present invention refers to a composition of (poly)phenol metabolite-based compounds. With a unique mode-of-action not toxic for the cells, our invention targets neuroinflammation […]

A portable, energy-free liquid crystal-based optical instrument that uses engineered proteins to detect bacteria at point of use. This technology refers to engineered recombinant proteins that bind to peptidoglycan (PG), a structure unique and ubiquitous to bacteria.[…]

An in vitro cellular culture development for novel therapeutic testing/pre-clinical research for novel anti-eye diabetic drugs for DR. This technology is an in vitro cellular culture development for novel therapeutic testing/pre-clinical research for novel anti-eye diabetic drugs for diabetic retino[…]